BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15282744)

  • 21. Cre recombinase-mediated gene targeting of mesenchymal cells.
    Florin L; Alter H; Gröne HJ; Szabowski A; Schütz G; Angel P
    Genesis; 2004 Mar; 38(3):139-44. PubMed ID: 15048811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
    Licht AH; Raab S; Hofmann U; Breier G
    Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential oocyte-specific expression of Cre recombinase activity in GDF-9-iCre, Zp3cre, and Msx2Cre transgenic mice.
    Lan ZJ; Xu X; Cooney AJ
    Biol Reprod; 2004 Nov; 71(5):1469-74. PubMed ID: 15215191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific expression of Cre recombinase in hypertrophic cartilage under the control of a BAC-Col10a1 promoter.
    Gebhard S; Hattori T; Bauer E; Schlund B; Bösl MR; de Crombrugghe B; von der Mark K
    Matrix Biol; 2008 Oct; 27(8):693-9. PubMed ID: 18692570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanical strain effect on bone-resorbing activity and messenger RNA expressions of marker enzymes in isolated osteoclast culture.
    Kurata K; Uemura T; Nemoto A; Tateishi T; Murakami T; Higaki H; Miura H; Iwamoto Y
    J Bone Miner Res; 2001 Apr; 16(4):722-30. PubMed ID: 11316000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues.
    Liu F; Woitge HW; Braut A; Kronenberg MS; Lichtler AC; Mina M; Kream BE
    Int J Dev Biol; 2004 Sep; 48(7):645-53. PubMed ID: 15470637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic targeting of principal neurons in neocortex and hippocampus of NEX-Cre mice.
    Goebbels S; Bormuth I; Bode U; Hermanson O; Schwab MH; Nave KA
    Genesis; 2006 Dec; 44(12):611-21. PubMed ID: 17146780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cathepsin K-Cre causes unexpected germline deletion of genes in mice.
    Winkeler CL; Kladney RD; Maggi LB; Weber JD
    PLoS One; 2012; 7(7):e42005. PubMed ID: 22860046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
    Jin C; McKeehan K; Wang F
    Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium.
    el Marjou F; Janssen KP; Chang BH; Li M; Hindie V; Chan L; Louvard D; Chambon P; Metzger D; Robine S
    Genesis; 2004 Jul; 39(3):186-93. PubMed ID: 15282745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Collagen1alpha1 promoter drives the expression of Cre recombinase in osteoblasts of transgenic mice.
    Zha L; Hou N; Wang J; Yang G; Gao Y; Chen L; Yang X
    J Genet Genomics; 2008 Sep; 35(9):525-30. PubMed ID: 18804071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitf-PU.1 interactions with the tartrate-resistant acid phosphatase gene promoter during osteoclast differentiation.
    Partington GA; Fuller K; Chambers TJ; Pondel M
    Bone; 2004 Feb; 34(2):237-45. PubMed ID: 14962802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reporter gene recombination in juxtaglomerular granular and collecting duct cells by human renin promoter-Cre recombinase transgene.
    Castrop H; Oppermann M; Weiss Y; Huang Y; Mizel D; Lu H; Germain S; Schweda F; Theilig F; Bachmann S; Briggs J; Kurtz A; Schnermann J
    Physiol Genomics; 2006 Apr; 25(2):277-85. PubMed ID: 16418317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conditional gene targeting in mouse pancreatic ß-Cells: analysis of ectopic Cre transgene expression in the brain.
    Wicksteed B; Brissova M; Yan W; Opland DM; Plank JL; Reinert RB; Dickson LM; Tamarina NA; Philipson LH; Shostak A; Bernal-Mizrachi E; Elghazi L; Roe MW; Labosky PA; Myers MG; Gannon M; Powers AC; Dempsey PJ
    Diabetes; 2010 Dec; 59(12):3090-8. PubMed ID: 20802254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene deletion in urothelium by specific expression of Cre recombinase.
    Mo L; Cheng J; Lee EY; Sun TT; Wu XR
    Am J Physiol Renal Physiol; 2005 Sep; 289(3):F562-8. PubMed ID: 15840768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the mouse tartrate-resistant acid phosphatase (TRAP) gene promoter.
    Reddy SV; Hundley JE; Windle JJ; Alcantara O; Linn R; Leach RJ; Boldt DH; Roodman GD
    J Bone Miner Res; 1995 Apr; 10(4):601-6. PubMed ID: 7610931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lcn5 promoter directs the region-specific expression of cre recombinase in caput epididymidis of transgenic mice.
    Xie S; Xu J; Ma W; Liu Q; Han J; Yao G; Huang X; Zhang Y
    Biol Reprod; 2013 Mar; 88(3):71. PubMed ID: 23349236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advantages and Limitations of Cre Mouse Lines Used in Skeletal Research.
    Elefteriou F; Couasnay G
    Methods Mol Biol; 2021; 2230():39-59. PubMed ID: 33197007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.